Anti-CD79b Antibody (Iladatuzumab vedotin)
Catalog No.
F1125
Anti-CD79b Antibody (Iladatuzumab vedotin)
Featured Products
Iladatuzumab vedotin (DCDS0780A;RO7032005) is an antibody-drug conjugate (ADC) consisting of CD79B (immunoglobulin-associated CD79 beta) antibody and cytotoxic agent monomethyl auristatin E (MMAE ) conjugated via a maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker. Iladatuzumab vedotin has the potential to be used in B-cell non-Hodgkin lymphoma (B-NHL) research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1906205-77-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
DCDS0780A, RO7032005
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P40259
Human
MMAE
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
The drug-to-antibody ratio (DAR) of the Anti-CD79b Reference Antibody (iladatuzumab vedotin) is 3.8.
CD79b
Please avoid freeze-thaw cycles.